Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Commonwealth Financial Services LLC

Commonwealth Financial Services LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 5.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 551 shares of the medical equipment provider’s stock after buying an additional 26 shares during the period. Commonwealth Financial Services LLC’s holdings in Intuitive Surgical were worth $288,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of ISRG. M.E. Allison & CO. Inc. purchased a new stake in Intuitive Surgical during the fourth quarter worth approximately $449,000. Seilern Investment Management Ltd purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $82,517,000. Exome Asset Management LLC boosted its holdings in shares of Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after buying an additional 1,069 shares in the last quarter. Consolidated Planning Corp grew its position in shares of Intuitive Surgical by 17.4% in the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after buying an additional 1,198 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC grew its position in shares of Intuitive Surgical by 73.2% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 270,029 shares of the medical equipment provider’s stock valued at $132,657,000 after buying an additional 114,149 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ISRG has been the topic of several research reports. Raymond James raised their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Evercore ISI raised their price target on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Mizuho boosted their price objective on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Check Out Our Latest Research Report on Intuitive Surgical

Insider Transactions at Intuitive Surgical

In related news, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 28,843 shares of company stock valued at $15,357,560 in the last ninety days. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $578.55 on Tuesday. The stock has a fifty day moving average price of $550.40 and a 200 day moving average price of $510.02. The stock has a market cap of $206.07 billion, a PE ratio of 90.26, a P/E/G ratio of 5.51 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

About Intuitive Surgical

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Recommended Stories

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.